Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Heart disease risk greater for women with a common condition they may not be aware they have - 2Pulsars to the extreme: Spinning dead stars found blasting radio signals from the 'edge of their magnetic reach'
- 3Bennu asteroid samples provide clues about solar system origins and 'space gum'
- 4Which Countries Would Suffer Most in a Global Energy Shutdown? This Study Has Answers
- 5Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- Which sandwich do you find totally delectable? !
- Phenomenal Web-based MBA Stages for Proficient Headway
- Instructions to Discuss Successfully with Your Auto Collision Lawyer
- 6 Famous Urban communities for Shopping on the planet
- Portable Installment Answers for Independent ventures
- 7 Moves toward a Sound and Dynamic Way of life
- RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record
- The Most Astonishing Arising Advances to Watch
- Meet Beef the bulldog, who takes slow walks with his 78-year-old friend
